WCN25-4372 A PROSPECTIVE, SINGLE-CENTRE STUDY ON THE EFFICACY AND SAFETY OF DESIDUSTAT IN CHRONIC KIDNEY DISEASE-INDUCED ANEMIA

Anemia in Chronic Kidney Disease (CKD) is a multifactorial disorder primarily treated with erythropoietin (EpO) analogs. Desidustat, a novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI), offers a convenient oral alternative to subcutaneous EpO injections for treating anemia in both dialysis-dependent and non-dialysis CKD (ND-CKD) patients. This study aims to prospectively evaluate the efficacy and safety of Desidustat in patients with CKD-induced anemia.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-01-27
DOI
https://doi.org/10.1016/j.ekir.2024.11.285
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WCN25-4372 A PROSPECTIVE, SINGLE-CENTRE STUDY ON THE EFFICACY AND SAFETY OF DESIDUSTAT IN CHRONIC KIDNEY DISEASE-INDUCED ANEMIA

Ishrat Mir, Acharan S. Narula, Sanshriti Chauhan, Anurag Gupta et al.
Kidney International Reports
Erythropoietin and Anemia Treatment
article

WCN25-4372 A PROSPECTIVE, SINGLE-CENTRE STUDY ON THE EFFICACY AND SAFETY OF DESIDUSTAT IN CHRONIC KIDNEY DISEASE-INDUCED ANEMIA

Ishrat Mir, Acharan S. Narula, Sanshriti Chauhan, Anurag Gupta, Sanjeev Gulati
article en

Abstract

Anemia in Chronic Kidney Disease (CKD) is a multifactorial disorder primarily treated with erythropoietin (EpO) analogs. Desidustat, a novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI), offers a convenient oral alternative to subcutaneous EpO injections for treating anemia in both dialysis-dependent and non-dialysis CKD (ND-CKD) patients. This study aims to prospectively evaluate the efficacy and safety of Desidustat in patients with CKD-induced anemia.

Kidney International ReportsVol. 10(2)
Fortis Healthcare (IN), Fortis Escorts Heart Institute (IN), Fortis Hospital (IN)
Openalex Percentile: Top 98%
Erythropoietin and Anemia Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.